Treatment With 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients With Recent Acute Coronary Syndrome-Reference-Cited by-同舟云学术

Treatment With 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients With Recent Acute Coronary Syndrome

Published:2010-05 Issue:3 Volume:3 Page:298-307
ISSN:1941-9651
Container-title:Circulation: Cardiovascular Imaging
language:en
Short-container-title:Circ Cardiovasc Imaging

Author:

Tardif Jean-Claude¹,L'Allier Philippe L.¹,Ibrahim Reda¹,Grégoire Jean C.¹,Nozza Anna¹,Cossette Mariève¹,Kouz Simon¹,Lavoie Marc-André¹,Paquin Janie¹,Brotz Tilmann M.¹,Taub Rebecca¹,Pressacco Josephine¹

Affiliation:

1. From the Department of Medicine (J.C.T., P.L.L, R.I., J.C.G., M.A.L), Radiology (J.Pa., J.Pr.), Montreal Heart Institute and Université de Montréal, Montreal, Canada; the Montreal Heart Institute Coordinating Center (MHICC) (A.N., M.C.), Montreal, Canada; Centre Hospitalier Régional de Lanaudière (S.K.), Joliette, Canada; and VIA Pharmaceuticals, San Francisco, CA (T.M.B.), Princeton, NJ (R.T.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Reference23 articles.

1. Atherosclerosis — An Inflammatory Disease

2. Atherosclerosis

3. Atherosclerosis

4. Inflammation in atherosclerosis

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standards for quantitative assessments by coronary computed tomography angiography (CCTA);Journal of Cardiovascular Computed Tomography;2024-09

2. Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the Tirzepatide treatment on coronary atherosclerosis progression: The (T-PLAQUE) randomized-controlled trial design;American Heart Journal;2024-08

3. Fatal attractions that trigger inflammation and drive atherosclerotic disease;European Journal of Clinical Investigation;2024-01-29

4. Noncoding RNAs: Versatile regulators of endothelial dysfunction;Life Sciences;2023-12

5. Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling;eBioMedicine;2022-12